Search research articles
Contact Us
Filters
Showing results (141-150 of 218) with videos related to
Page
of 22
Sort By:
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
Anticancer Research
|
August 10, 2002
A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines
P Lissoni, R Bucovec, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
European Journal of Cancer
|
September 1, 1979
Small cell carcinoma of the lung: a combined modality treatment
P van Houtte, G Tancini, R de Jager, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2
P Lissoni, A Ardizzoia, E Tisi, et al.
The International Journal of Biological Markers
|
April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer
S Barni, P Lissoni, D Mandelli, et al.
Tumori
|
December 31, 1993
A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma
P Lissoni, S Barni, A Ardizzoia, et al.
Neuro Endocrinology Letters
|
May 4, 2001
Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer
P Lissoni, M Vaghi, A Ardizzoia, et al.
The International Journal of Biological Markers
|
October 1, 1990
Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome
P Lissoni, S Barni, G Cattaneo, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 218) with videos related to
Sort By:
Page
of 22
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
Anticancer Research
|
August 10, 2002
A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines
P Lissoni, R Bucovec, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
European Journal of Cancer
|
September 1, 1979
Small cell carcinoma of the lung: a combined modality treatment
P van Houtte, G Tancini, R de Jager, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2
P Lissoni, A Ardizzoia, E Tisi, et al.
The International Journal of Biological Markers
|
April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer
S Barni, P Lissoni, D Mandelli, et al.
Tumori
|
December 31, 1993
A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma
P Lissoni, S Barni, A Ardizzoia, et al.
Neuro Endocrinology Letters
|
May 4, 2001
Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer
P Lissoni, M Vaghi, A Ardizzoia, et al.
The International Journal of Biological Markers
|
October 1, 1990
Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome
P Lissoni, S Barni, G Cattaneo, et al.
Page
of 22